RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Pluristem Therapeutics Stock and on which exchange is it traded?
The symbol for Pluristem Therapeutics is PSTI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pluristem Therapeutics Stock?
Pluristem Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Pluristem Therapeutics Stock?
Pluristem Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pluristem Therapeutics Stock.

What's the current price of Pluristem Therapeutics Stock?
As of the end of day on the 2022-11-04, the price of an Pluristem Therapeutics (PSTI) share was $0.85.

What is the 52-week high and low for Pluristem Therapeutics Stock?
The 52-week high for Pluristem Therapeutics Stock is $3.19 and the 52-week low is $0.650.

What is the market capitalization of Pluristem Therapeutics Stock?
As of the 2022-11-04, the market capitalization of Pluristem Therapeutics is 40.848M.
Click to get the best stock tips daily for free!

About Pluristem Therapeutics

Pluristem Therapeutics Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recove... PSTI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT